
Glispo PM 2mg/500mg/15mg Tablet SR
Marketer
Wells Biosciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glispo PM 2mg/500mg/15mg Tablet SR
Diabetic patients may find relief with the extended-release combination medication, Glispo PM 2mg/500mg/15mg Tablet SR. This medication assists in regulating blood glucose, complementing a healthy diet and exercise program for improved glycemic control in adults with type 2 diabetes. Its mechanism involves enhancing insulin effectiveness, thus reducing blood sugar. Follow your physician's prescribed dosage and schedule meticulously. Ingest the medication with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in that case, omit the missed dose and resume the usual schedule. Never double the dose to compensate for a missed one, as an overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals elevates the hypoglycemia risk; diligent blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Consult your doctor if you are pregnant, breastfeeding, or planning pregnancy. Renal function assessment will precede treatment initiation. Limit alcohol consumption during treatment to mitigate potential adverse effects.
Uses of Glispo PM 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glispo PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glispo PM 2mg/500mg/15mg sustained-release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Glispo PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glispo PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glispo PM 2mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.
How Glispo PM 2mg/500mg/15mg Tablet SR works:
Glispo PM 2mg/500mg/15mg Extended-Release Tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct pathways to optimize blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glispo PM 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glispo PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Glispo PM 2mg/500mg/15mg Tablet SR while breastfeeding is likely inadvisable. Available data from humans indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glispo PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glispo PM 2mg/500mg/15mg SR tablets. Physician consultation is essential. Kidney function should be regularly monitored during treatment.
LiverCAUTION
Patients with liver impairment should use Glispo PM 2mg/500mg/15mg SR tablets cautiously, as dose modification may be necessary. Consult a physician for guidance. Glispo PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glispo PM 2mg/500mg/15mg Tablet SR :
Should you forget a Glispo PM 2mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glispo PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
